Overview

Study to Compare Conivaptan in Subjects With Mild & Moderate Liver Impairment Versus Subjects With Normal Liver Function

Status:
Completed

Trial end date:
2010-01-01

Target enrollment:

Participant gender:

Summary

A study to compare a 48-hour continuous infusion of conivaptan in subjects with mild and moderate liver impairment versus subjects with normal liver function

Phase:

Phase 1

Details

Lead Sponsor:

Cumberland Pharmaceuticals

Treatments:

Conivaptan